McKESSON CORPORATION Share Repurchase Authorization
McKESSON CORPORATION (MCK) had Share Repurchase Authorization of $5.00 billion as of 2026-04-29, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Equity
srt:StockRepurchaseProgramAuthorizedAmount1 · last filed 2026-08-05
- 2026-04-29: Stock Repurchase Program Authorized Amount1 $5.00B.
- 2025-07-31: Stock Repurchase Program Authorized Amount1 $4.00B.
- 2025-03-31: Stock Repurchase Program Authorized Amount1 $4.00B.
- 2024-07-31: Stock Repurchase Program Authorized Amount1 $4.00B.
| Period end | Stock Repurchase Program Authorized Amount1 |
|---|---|
| 2026-04-29 | $5.00B 10-Q · filed 2026-08-05 |
| 2025-07-31 | $4.00B 10-Q · filed 2025-11-06 |
| 2025-03-31 | $4.00B 10-K · filed 2026-05-08 |
| 2024-07-31 | $4.00B 10-Q · filed 2026-02-04 |
| 2024-03-31 | $6.00B 10-K · filed 2026-05-08 |
| 2023-03-31 | $4.00B 10-K · filed 2025-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cencora, Inc. (COR) | United States | $59.130B | 20.57 |
| CARDINAL HEALTH INC (CAH) | United States | $51.753B | 29.38 |
| HERBALIFE LTD. (HLF) | $1.281B | 8.39 | |
| NU SKIN ENTERPRISES, INC. (NUS) | United States | $0.225B | -1.18 |
| Cosmos Health Inc. (COSM) | Greece | $0.038B | -0.60 |
| HWH International Inc. (HWH) | United States | $0.021B | -4.08 |
| DataMeds AI, Inc. (MEDS) | United States | $0.011B |